Name: Diagnostic Electrocardiograph/ECG Market by Product (Resting ECG, Stress ECG, Mobile Cardiac Telemetry), Lead Type (Single-lead, 3, 5, 6 & 12-lead ECG Device), Type (Portable ECG Device, Wearable ECG Device), Connectivity - Global Forecast to 2032
Brand: MarketsandMarkets
SKU: MD2551
Price: 4950 USD
Availability: InStock

1 INTRODUCTION 30 1.1 STUDY OBJECTIVES 30 1.2 MARKET DEFINITION 30 1.3 STUDY SCOPE 31 1.3.1 SEGMENTS CONSIDERED & GEOGRAPHICAL SCOPE 31 1.3.2 INCLUSIONS & EXCLUSIONS 32 1.3.3 YEARS CONSIDERED 33 1.4 CURRENCY CONSIDERED 33 1.5 STAKEHOLDERS 34 1.6 SUMMARY OF CHANGES 34 2 RESEARCH METHODOLOGY 35 2.1 RESEARCH DATA 35 2.1.1 SECONDARY DATA 36 2.1.1.1 Key data from secondary sources 37 2.1.2 PRIMARY DATA 37 2.1.2.1 Primary sources 38 2.1.2.2 Key industry insights 39 2.1.2.3 Breakdown of primaries 39 2.2 MARKET SIZE ESTIMATION OF DIAGNOSTIC ECG PRODUCTS 40 2.2.1 REVENUE SHARE ANALYSIS (BOTTOM-UP APPROACH) 41 2.2.2 MNM REPOSITORY ANALYSIS 42 2.2.3 COMPANY INVESTOR PRESENTATIONS AND PRIMARY INTERVIEWS 42 2.2.4 TOP-DOWN APPROACH 42 2.2.5 BOTTOM-UP APPROACH 43 2.2.6 PRIMARY INTERVIEWS 43 2.2.7 DEMAND-SIDE APPROACH 43 2.2.8 VOLUME DATA ANALYSIS 44 2.3 MARKET GROWTH RATE PROJECTION 44 2.4 DATA TRIANGULATION 45 2.4.1 STUDY ASSUMPTIONS 46 2.4.2 RESEARCH LIMITATIONS 46 2.5 RISK ANALYSIS 47 3 EXECUTIVE SUMMARY 48 4 PREMIUM INSIGHTS 52 4.1 DIAGNOSTIC ECG MARKET OVERVIEW 52 4.2 NORTH AMERICA: DIAGNOSTIC ECG MARKET SHARE, BY TYPE AND COUNTRY (2024) 53 4.3 DIAGNOSTIC ECG DEVICES MARKET SHARE, BY DEVICE TYPE, 2025 VS. 2032 53 4.4 DIAGNOSTIC ECG MARKET, BY LEAD TYPE, 2025 VS. 2032 (USD MILLION) 54 4.5 DIAGNOSTIC ECG MARKET, BY END USER, 2025 VS. 2032 (USD MILLION) 55 4.6 DIAGNOSTIC ECG MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 56 5 MARKET OVERVIEW 57 5.1 INTRODUCTION 57 5.2 MARKET DYNAMICS 57 5.2.1 DRIVERS 58 5.2.1.1 Increasing incidence of lifestyle and cardiovascular diseases 58 5.2.1.2 Rapidly expanding global geriatric population and subsequent surge in heart conditions 58 5.2.1.3 Development of wireless monitoring and wearable cardiac devices 59 5.2.1.4 Growing need for cost-containment across healthcare facilities 59 5.2.2 RESTRAINTS 60 5.2.2.1 Stringent regulatory requirements delaying approval of cardiac devices 60 5.2.2.2 Technological limitations of diagnostic ECG devices and software 60 5.2.3 OPPORTUNITIES 61 5.2.3.1 Emerging markets to offer high-growth opportunities 61 5.2.3.2 Expanding access to advanced cardiac diagnostics with AI and CMS support 62 5.2.4 CHALLENGES 62 5.2.4.1 Challenges in integrating ECG systems with Electronic Health Records (EHRs) 62 5.2.4.2 Accuracy challenges in next-generation ECG monitoring 63 5.3 INDUSTRY TRENDS 63 5.3.1 MINIATURIZATION AND WEARABLE ECG DEVICES 63 5.3.2 REMOTE AND HOME-BASED DIAGNOSTICS 64 5.3.3 HIGH-FIDELITY AND MULTI-LEAD PORTABLE ECGS 64 5.4 TECHNOLOGY ANALYSIS 64 5.4.1 KEY TECHNOLOGIES 64 5.4.1.1 Wearable devices and sensors 64 5.4.1.2 Integration of Artificial Intelligence (AI) 65 5.4.2 COMPLEMENTARY TECHNOLOGIES 65 5.4.2.1 Wireless ECG devices 65 5.4.2.2 Mobile apps integration 66 5.4.3 ADJACENT TECHNOLOGIES 66 5.4.3.1 Vital sign monitors 66 5.5 PORTER’S FIVE FORCES ANALYSIS 67 5.5.1 THREAT OF NEW ENTRANTS 68 5.5.2 THREAT OF SUBSTITUTES 68 5.5.3 BARGAINING POWER OF BUYERS 68 5.5.4 BARGAINING POWER OF SUPPLIERS 68 5.5.5 INTENSITY OF COMPETITIVE RIVALRY 68 5.6 REGULATORY LANDSCAPE 68 5.6.1 REGULATORY ANALYSIS 68 5.6.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 69 5.6.3 REGULATORY FRAMEWORK 70 5.6.3.1 North America 70 5.6.3.1.1 US 70 5.6.3.1.2 Canada 70 5.6.3.2 Europe 71 5.6.3.3 Asia Pacific 71 5.6.3.3.1 China 71 5.6.3.3.2 Japan 71 5.6.3.3.3 India 71 5.6.3.4 Latin America 72 5.6.3.4.1 Brazil 72 5.6.3.4.2 Mexico 72 5.6.3.5 Middle East 72 5.6.3.6 Africa 73 5.7 PATENT ANALYSIS 73 5.7.1 PATENT PUBLICATION TRENDS FOR DIAGNOSTIC ECG 73 5.7.2 JURISDICTION AND TOP APPLICANT ANALYSIS 74 5.8 TRADE ANALYSIS 76 5.8.1 TRADE ANALYSIS FOR DIAGNOSTIC ECG PRODUCTS 76 5.8.2 TRADE DATA FOR HS CODE 901811 76 5.8.2.1 Import data for HS Code 901811 76 5.8.2.2 Export data for HS Code 901811 77 5.9 PRICING ANALYSIS 77 5.9.1 AVERAGE SELLING PRICE, BY KEY PLAYER 77 5.9.1.1 Average selling price of resting ECG, by key player 78 5.9.1.2 Average selling price for stress ECG, by key player 78 5.9.1.3 Average selling price of Holter monitors, by key player 79 5.9.2 AVERAGE SELLING PRICE, BY REGION 79 5.9.2.1 Average selling price of resting ECG, stress ECG, and Holter monitors, by region 79 5.10 REIMBURSEMENT SCENARIO 80 5.11 KEY CONFERENCES & EVENTS, 2025–2026 81 5.12 KEY STAKEHOLDERS & BUYING CRITERIA 82 5.12.1 KEY STAKEHOLDERS IN BUYING PROCESS 82 5.12.2 KEY BUYING CRITERIA 83 5.13 UNMET NEEDS/END-USER EXPECTATIONS 84 5.14 VALUE CHAIN ANALYSIS 85 5.15 SUPPLY CHAIN ANALYSIS 87 5.16 ECOSYSTEM ANALYSIS 88 5.17 IMPACT OF AI/GEN AI ON DIAGNOSTIC ECG MARKET 90 5.17.1 INTRODUCTION 90 5.17.2 MARKET POTENTIAL IN DIAGNOSTIC ECG ECOSYSTEM 90 5.17.3 AI USE CASES 91 5.17.4 KEY COMPANIES IMPLEMENTING AI IN DIAGNOSTIC ECG DEVICES 91 5.17.5 FUTURE OF GEN AI IN DIAGNOSTIC ECG ECOSYSTEM 92 5.18 CASE STUDY ANALYSIS 93 5.19 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 94 5.20 IMPACT OF 2025 US TARIFF 95 5.20.1 INTRODUCTION 95 5.20.2 KEY TARIFF RATES 96 5.20.3 PRICE IMPACT ANALYSIS 97 5.20.4 IMPACT ON COUNTRY/REGION 97 5.20.5 IMPACT ON END-USER INDUSTRIES 100 5.21 INVESTMENT AND FUNDING SCENARIO 101 6 DIAGNOSTIC ECG MARKET, BY PRODUCT 103 6.1 INTRODUCTION 104 6.2 DEVICES 104 6.2.1 RESTING ECG DEVICES 106 6.2.1.1 Wide availability of resting ECG devices to support market growth 106 6.2.2 STRESS ECG DEVICES 109 6.2.2.1 High cost of stress ECG devices to limit adoption 109 6.2.3 HOLTER MONITORS 111 6.2.3.1 Growing demand for continuous monitoring to fuel growth 111 6.2.4 EVENT MONITORS 113 6.2.4.1 Increasing outsourcing of monitoring devices to propel market growth 113 6.2.5 IMPLANTABLE LOOP RECORDERS 115 6.2.5.1 Introduction of technologically advanced implantable loop recorders to support market growth 115 6.2.6 MOBILE CARDIAC TELEMETRY DEVICES 117 6.2.6.1 Increasing demand for cardiac monitoring solutions in home care settings to propel market 117 6.2.7 SMART ECG MONITORS 119 6.2.7.1 Rising adoption of smart/wearable ECG monitors 119 6.3 SOFTWARE & SERVICES 121 6.3.1 SHIFT TOWARD AI-ENABLED ECG SOFTWARE TO SUPPORT GROWTH 121 7 DIAGNOSTIC ECG MARKET, BY LEAD TYPE 123 7.1 INTRODUCTION 124 7.2 12-LEAD ECG DEVICES 124 7.2.1 GROWING USE IN PRE-HOSPITAL AND CLINIC SETTINGS TO DRIVE MARKET GROWTH 124 7.3 5-LEAD ECG DEVICES 127 7.3.1 GROWING IMPORTANCE OF PATIENT MONITORING TO BOOST ADOPTION 127 7.4 3-LEAD ECG DEVICES 129 7.4.1 VITAL TOOL FOR RHYTHM MONITORING TO SUPPORT MARKET GROWTH 129 7.5 6-LEAD ECG DEVICES 131 7.5.1 GROWING USE OF 6-LEAD ECG DEVICES IN REMOTE PATIENT MONITORING TO FAVOR MARKET GROWTH 131 7.6 SINGLE-LEAD ECG DEVICES 133 7.6.1 EASE OF USE FOR DIAGNOSIS AND QUICK RESULTS TO INCREASE USE OF SINGLE-LEAD ECG DEVICES 133 7.7 OTHER ECG LEAD DEVICES 135 8 DIAGNOSTIC ECG MARKET, BY TYPE 136 8.1 INTRODUCTION 137 8.2 PORTABLE 138 8.2.1 CONVENIENCE AND ACCESSIBILITY OF PORTABLE ECG DEVICES TO ENHANCE EARLY CARDIAC SCREENING 138 8.3 WEARABLE 140 8.3.1 RISING DEMAND FOR CONTINUOUS HEART MONITORING IN FITNESS AND CHRONIC DISEASE MANAGEMENT 140 8.4 IMPLANTABLE 142 8.4.1 HIGH DIAGNOSTIC YIELD FOR ELUSIVE CARDIAC CONDITIONS WITH LONG-TERM MONITORING 142 9 DIAGNOSTIC ECG MARKET, BY DEPLOYMENT/CONNECTIVITY 144 9.1 INTRODUCTION 145 9.2 STANDALONE ECG DEVICES 145 9.2.1 WIDESPREAD ADOPTION OF STANDALONE ECG DEVICES DUE TO OPERATIONAL SIMPLICITY 145 9.3 PC-BASED ECG DEVICES 147 9.3.1 GROWING USE FOR ADVANCED ECG DIAGNOSTICS AND INTEGRATION TO SUPPORT REMOTE CARDIAC CARE 147 9.4 CLOUD-BASED ECG DEVICES 149 9.4.1 ACCELERATED GROWTH OF CLOUD-BASED ECG SOLUTIONS TO SUPPORT REMOTE CARDIAC CARE 149 10 DIAGNOSTIC ECG MARKET, BY END USER 151 10.1 INTRODUCTION 152 10.2 HOSPITALS 152 10.2.1 INCREASING UTILIZATION OF ECG DEVICES IN HOSPITALS TO ACCELERATE MARKET GROWTH 152 10.3 PRIMARY CARE CENTERS 154 10.3.1 WIDENING ACCESS TO ECG DIAGNOSTICS IN PRIMARY CARE CENTERS TO BOOST MARKET PENETRATION 154 10.4 CARDIAC CENTERS 156 10.4.1 SPECIALIZED ECG APPLICATIONS IN CARDIAC CENTERS TO DRIVE DEMAND FOR ADVANCED DEVICES 156 10.5 AMBULATORY SURGICAL CENTERS 158 10.5.1 GROWING NEED FOR PRE-OPERATIVE CARDIAC SCREENING IN ASCS TO INFLUENCE MARKET DEMAND 158 10.6 HOME CARE SETTINGS 160 10.6.1 RISING PREFERENCE FOR REMOTE MONITORING FUELS ECG DEVICE USAGE IN HOME CARE 160 10.7 URGENT CARE SETTINGS 162 10.7.1 INTEGRATION OF DIAGNOSTIC ECG IN URGENT CARE SETTINGS FOR TIMELY CARDIAC EVALUATIONS TO FUEL MARKET DEMAND 162 10.8 OTHER END USERS 164 10.8.1 DIVERSE ECG APPLICATIONS ACROSS NURSING HOMES, RETAIL CLINICS, SPORTS MEDICINE & RESEARCH TO INFLUENCE MARKET DEMAND 164 11 DIAGNOSTIC ECG MARKET, BY REGION 166 11.1 INTRODUCTION 167 11.2 NORTH AMERICA 168 11.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA 168 11.2.2 US 173 11.2.2.1 US to command largest share in diagnostic ECG market 173 11.2.3 CANADA 177 11.2.3.1 Growing adoption of digital diagnostic ECG systems to drive market growth 177 11.3 EUROPE 180 11.3.1 MACROECONOMIC OUTLOOK FOR EUROPE 180 11.3.2 GERMANY 184 11.3.2.1 High healthcare spending to propel market growth 184 11.3.3 FRANCE 188 11.3.3.1 Government support for e-Health to propel market 188 11.3.4 UK 191 11.3.4.1 Rising demand for home-based smart ECG devices to support market growth 191 11.3.5 ITALY 194 11.3.5.1 Growing focus on improvements in patient care to drive market 194 11.3.6 SPAIN 198 11.3.6.1 Rising geriatric population to support market growth in Spain 198 11.3.7 REST OF EUROPE 201 11.4 ASIA PACIFIC 204 11.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC 205 11.4.2 JAPAN 210 11.4.2.1 High healthcare expenditure and favorable reimbursement and insurance coverage to support market growth in Japan 210 11.4.3 CHINA 214 11.4.3.1 Government support for infrastructural improvement to drive market growth 214 11.4.4 INDIA 218 11.4.4.1 Increasing cardiac disease burden intensifies demand for ECG diagnostics 218 11.4.5 AUSTRALIA 221 11.4.5.1 Increased patient volume and favorable government initiatives to drive market 221 11.4.6 SOUTH KOREA 224 11.4.6.1 Rising geriatric population to propel market growth 224 11.4.7 MALAYSIA 227 11.4.7.1 Increasing CVD burden and national digital health initiatives driving ECG adoption 227 11.4.8 THAILAND 230 11.4.8.1 National cardiac screening programs and smart hospital investments driving ECG adoption in Thailand 230 11.4.9 INDONESIA 233 11.4.9.1 Rising cardiac disease burden and public health digitalization efforts to drive ECG device uptake in Indonesia 233 11.4.10 REST OF ASIA PACIFIC 236 11.5 LATIN AMERICA 239 11.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA 240 11.5.2 BRAZIL 243 11.5.2.1 Improving access to diagnostic services to drive growth 243 11.5.3 MEXICO 246 11.5.3.1 Rising heart disease to drive market growth 246 11.5.4 REST OF LATIN AMERICA 249 11.6 MIDDLE EAST & AFRICA 252 11.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA 252 11.6.2 GCC COUNTRIES 256 11.6.2.1 Kingdom of Saudi Arabia (KSA) 260 11.6.2.1.1 Prevalence of CVDs boosting ECG adoption in Saudi Arabia 260 11.6.2.2 United Arab Emirates (UAE) 264 11.6.2.2.1 National CVD screening programs and digital health strategies driving market 264 11.6.2.3 Rest of GCC Countries 267 11.6.3 REST OF MIDDLE EAST & AFRICA 270 12 COMPETITIVE LANDSCAPE 274 12.1 INTRODUCTION 274 12.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 274 12.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN DIAGNOSTIC ECG MARKET 274 12.3 REVENUE SHARE ANALYSIS (2022-2024) 276 12.4 MARKET SHARE ANALYSIS, 2024 277 12.4.1 RANKING OF KEY PLAYERS 280 12.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024 280 12.5.1 STARS 280 12.5.2 EMERGING LEADERS 280 12.5.3 PERVASIVE PLAYERS 281 12.5.4 PARTICIPANTS 281 12.5.5 COMPANY PRODUCT FOOTPRINT: KEY PLAYERS, 2024 282 12.5.5.1 Company footprint 282 12.5.5.2 Region footprint 283 12.5.5.3 Product footprint 284 12.5.5.4 Lead type footprint 285 12.5.5.5 Type footprint 286 12.5.5.6 Deployment/Connectivity footprint 287 12.6 COMPANY EVALUATION MATRIX FOR STARTUPS/SMES, 2024 287 12.6.1 PROGRESSIVE COMPANIES 287 12.6.2 RESPONSIVE COMPANIES 288 12.6.3 DYNAMIC COMPANIES 288 12.6.4 STARTING BLOCKS 288 12.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024 289 12.6.5.1 Detailed list of key startups/SME players 289 12.6.5.2 Competitive benchmarking of key startups/SME players 290 12.7 BRAND/PRODUCT COMPARISON 291 12.8 DIAGNOSTIC ECG MARKET: COMPANY VALUATION & FINANCIAL METRICS 292 12.8.1 FINANCIAL METRICS 292 12.8.2 COMPANY VALUATION 292 12.9 COMPETITIVE SCENARIO 293 12.9.1 PRODUCT LAUNCHES & APPROVALS 293 12.9.2 DEALS 295 12.9.3 EXPANSIONS 297 12.9.4 OTHER DEVELOPMENTS 298 13 COMPANY PROFILES 300 13.1 KEY PLAYERS 300 13.1.1 KONINKLIJKE PHILIPS N.V. 300 13.1.1.1 Business overview 300 13.1.1.2 Products/Services/Solutions offered 301 13.1.1.3 Recent developments 303 13.1.1.3.1 Product/Service launches 303 13.1.1.3.2 Deals 304 13.1.1.3.3 Other developments 304 13.1.1.4 MnM view 304 13.1.1.4.1 Key strengths/Right to win 304 13.1.1.4.2 Strategic choices 305 13.1.1.4.3 Weaknesses and competitive threats 305 13.1.2 GE HEALTHCARE 306 13.1.2.1 Business overview 306 13.1.2.2 Products offered 307 13.1.2.3 Recent developments 308 13.1.2.3.1 Deals 308 13.1.2.3.2 Other developments 309 13.1.2.4 MnM view 309 13.1.2.4.1 Key strengths/Right to win 309 13.1.2.4.2 Strategic choice 310 13.1.2.4.3 Weaknesses and competitive threats 310 13.1.3 MEDTRONIC 311 13.1.3.1 Business overview 311 13.1.3.2 Products offered 312 13.1.3.3 MnM view 313 13.1.3.3.1 Right to win 313 13.1.3.3.2 Strategic choices 313 13.1.3.3.3 Weaknesses and competitive threats 313 13.1.4 BOSTON SCIENTIFIC CORPORATION 314 13.1.4.1 Business overview 314 13.1.4.2 Products offered 316 13.1.4.3 MnM view 316 13.1.4.3.1 Right to win 316 13.1.4.3.2 Strategic choices 316 13.1.4.3.3 Weaknesses and competitive threats 316 13.1.5 ABBOTT LABORATORIES 317 13.1.5.1 Business overview 317 13.1.5.2 Products offered 318 13.1.5.3 Recent developments 319 13.1.5.3.1 Product launches 319 13.1.5.4 MnM view 319 13.1.5.4.1 Key strengths 319 13.1.5.4.2 Strategic choices 319 13.1.5.4.3 Weaknesses & competitive threats 319 13.1.6 BAXTER (HILL-ROM HOLDINGS, INC.) 320 13.1.6.1 Business overview 320 13.1.6.2 Products offered 321 13.1.6.3 MnM view 323 13.1.6.3.1 Key strengths/Right to win 323 13.1.6.3.2 Strategic choices 323 13.1.6.3.3 Weaknesses & competitive threats 324 13.1.7 FUKUDA DENSHI 325 13.1.7.1 Business overview 325 13.1.7.2 Products offered 326 13.1.7.3 MnM view 327 13.1.7.3.1 Key strengths 327 13.1.7.3.2 Strategic choices 327 13.1.7.3.3 Weaknesses & competitive threats 327 13.1.8 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD. 328 13.1.8.1 Business overview 328 13.1.8.2 Products offered 329 13.1.8.3 MnM view 330 13.1.8.3.1 Key strengths 330 13.1.8.3.2 Strategic choices 330 13.1.8.3.3 Weaknesses & competitive threats 330 13.1.9 NIHON KOHDEN CORPORATION 331 13.1.9.1 Business overview 331 13.1.9.2 Products offered 332 13.1.10 OSI SYSTEMS, INC. 334 13.1.10.1 Business overview 334 13.1.10.2 Products offered 335 13.1.10.3 Recent developments 336 13.1.10.3.1 Expansions 336 13.1.11 BITTIUM 337 13.1.11.1 Business overview 337 13.1.11.2 Products offered 338 13.1.11.3 Recent developments 339 13.1.11.3.1 Deals 339 13.1.12 IRHYTHM TECHNOLOGIES, INC. 340 13.1.12.1 Business overview 340 13.1.12.2 Products offered 341 13.1.12.3 Recent developments 341 13.1.12.3.1 Product launches and approvals 341 13.1.12.3.2 Deals 342 13.1.13 LEPU MEDICAL TECHNOLOGY (BEIJING) CO., LTD. 343 13.1.13.1 Business overview 343 13.1.13.2 Products offered 344 13.1.13.3 Recent developments 345 13.1.13.3.1 Product launches and approvals 345 13.1.13.3.2 Other developments 346 13.1.14 MIDMARK CORPORATION 347 13.1.14.1 Business overview 347 13.1.14.2 Products offered 347 13.1.14.3 Recent developments 348 13.1.14.3.1 Product launches 348 13.1.15 BPL MEDICAL TECHNOLOGIES 349 13.1.15.1 Business overview 349 13.1.15.2 Products offered 349 13.1.15.3 Recent developments 350 13.1.15.3.1 Expansions 350 13.1.15.3.2 Other developments 351 13.1.16 SCHILLER 352 13.1.16.1 Business overview 352 13.1.16.2 Products offered 352 13.1.16.3 Recent developments 353 13.1.16.3.1 Product launches 353 13.1.16.3.2 Other developments 353 13.1.17 ACS DIAGNOSTICS 354 13.1.17.1 Business overview 354 13.1.17.2 Products offered 354 13.1.18 ALLENGERS 355 13.1.18.1 Business overview 355 13.1.18.2 Products offered 355 13.1.19 BIONET CO., LTD. 356 13.1.19.1 Business overview 356 13.1.19.2 Products offered 356 13.1.19.3 Recent developments 357 13.1.19.3.1 Other developments 357 13.2 OTHER PLAYERS 358 13.2.1 EDAN INSTRUMENTS, INC. 358 13.2.2 QINGDAO MEDITECH EQUIPMENT CO., LTD. 359 13.2.3 CARDIAC INSIGHT, INC. 360 13.2.4 ALIVECOR, INC. 360 13.2.5 VITALCONNECT 361 13.2.6 BTL 362 13.2.7 BORSAM MEDICAL 363 13.2.8 NASIFF ASSOCIATES, INC. 363 13.2.9 VECTRACOR, INC. 364 13.2.10 BIOMEDICAL INSTRUMENTS CO., LTD. 364 13.2.11 LIFESIGNALS 365 14 APPENDIX 366 14.1 DISCUSSION GUIDE 366 14.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 370 14.3 CUSTOMIZATION OPTIONS 372 14.4 RELATED REPORTS 372 14.5 AUTHOR DETAILS 373

TABLE 1 DIAGNOSTIC ECG MARKET: INCLUSIONS & EXCLUSIONS 32 TABLE 2 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD 33 TABLE 3 DIAGNOSTIC ECG MARKET: STUDY ASSUMPTIONS 46 TABLE 4 DIAGNOSTIC ECG MARKET: RISK ANALYSIS 47 TABLE 5 DIAGNOSTIC ECG MARKET: PORTER’S FIVE FORCES ANALYSIS 67 TABLE 6 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 69 TABLE 7 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 69 TABLE 8 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 69 TABLE 9 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 70 TABLE 10 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 70 TABLE 11 DIAGNOSTIC ECG MARKET: INNOVATIONS AND PATENT REGISTRATIONS, 2023–2025 75 TABLE 12 IMPORT DATA FOR HS CODE 901811 (ELECTRO-CARDIOGRAPHS), BY COUNTRY, 2021–2024 (USD THOUSAND) 76 TABLE 13 EXPORT DATA FOR HS CODE 901811 (ELECTRO-CARDIOGRAPHS), BY COUNTRY, 2021–2024 (USD THOUSAND) 77 TABLE 14 AVERAGE SELLING PRICE TREND OF RESTING ECG, BY REGION, 2022–2024 80 TABLE 15 AVERAGE SELLING PRICE TREND OF STRESS ECG, BY REGION, 2022–2024 80 TABLE 16 AVERAGE SELLING PRICE TREND OF HOLTER MONITORS, BY REGION, 2022–2024 80 TABLE 17 COMMON CPT CODES AND AVERAGE REIMBURSEMENT RATES 81 TABLE 18 DIAGNOSTIC ECG MARKET: DETAILED LIST OF CONFERENCES & EVENTS 81 TABLE 19 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY PRODUCT 83 TABLE 20 KEY BUYING CRITERIA FOR DIAGNOSTIC ECG PRODUCTS 83 TABLE 21 DIAGNOSTIC ECG MARKET: CURRENT UNMET NEEDS 84 TABLE 22 DIAGNOSTIC ECG PROVIDERS: ROLE OF COMPANIES IN ECOSYSTEM 89 TABLE 23 KEY COMPANIES IMPLEMENTING AI IN DIAGNOSTIC ECG DEVICES 92 TABLE 24 CASE STUDY 1: ARRHYTHMIA DETECTION IN SINGLE-LEAD ECG CHEST STRAP 93 TABLE 25 CASE STUDY 2: CARDIOSOFT ECG - BICESTER HEALTH CENTRE 93 TABLE 26 CASE STUDY 3: ENHANCING POST-STROKE ATRIAL FIBRILLATION DETECTION WITH PHILIPS BIOTEL HEART MCOT 94 TABLE 27 US-ADJUSTED RECIPROCAL TARIFF RATES 96 TABLE 28 KEY PRODUCT-RELATED TARIFF EFFECTIVE FOR DIAGNOSTIC ELECTROCARDIOGRAPHS 96 TABLE 29 NORTH AMERICA: IMPACT ON CANADA DUE TO US TARIFFS 97 TABLE 30 ASIA PACIFIC: IMPACT ON CHINA, JAPAN, AND INDIA DUE TO US TARIFFS 98 TABLE 31 EUROPE: IMPACT ON GERMANY AND UK DUE TO US TARIFFS 99 TABLE 32 LATIN AMERICA: IMPACT ON MEXICO DUE TO US TARIFFS 100 TABLE 33 DIAGNOSTIC ECG MARKET, BY PRODUCT, 2023–2032 (USD MILLION) 104 TABLE 34 KEY PLAYERS PROVIDING DIAGNOSTIC ECG DEVICES 105 TABLE 35 DIAGNOSTIC ECG DEVICES MARKET, BY TYPE, 2023–2032 (USD MILLION) 106 TABLE 36 KEY PLAYERS PROVIDING RESTING ECG DEVICES 107 TABLE 37 RESTING ECG DEVICES MARKET, BY COUNTRY/REGION, 2023–2032 (USD MILLION) 108 TABLE 38 KEY PLAYERS PROVIDING STRESS ECG DEVICES 109 TABLE 39 STRESS ECG DEVICES MARKET, BY COUNTRY/REGION, 2023–2032 (USD MILLION) 110 TABLE 40 KEY PLAYERS PROVIDING HOLTER MONITORS 111 TABLE 41 HOLTER MONITORS MARKET, BY COUNTRY/REGION, 2023–2032 (USD MILLION) 112 TABLE 42 KEY PLAYERS PROVIDING EVENT MONITORS 113 TABLE 43 EVENT MONITORS MARKET, BY COUNTRY/REGION, 2023–2032 (USD MILLION) 114 TABLE 44 IMPLANTABLE LOOP RECORDERS MARKET, BY COUNTRY/REGION, 2023–2032 (USD MILLION) 116 TABLE 45 MOBILE CARDIAC TELEMETRY DEVICES MARKET, BY COUNTRY/REGION, 2023–2032 (USD MILLION) 118 TABLE 46 SMART ECG MONITORS MARKET, BY COUNTRY/REGION, 2023–2032 (USD MILLION) 120 TABLE 47 DIAGNOSTIC ECG SOFTWARE & SERVICES MARKET, BY COUNTRY/REGION, 2023–2032 (USD MILLION) 122 TABLE 48 DIAGNOSTIC ECG MARKET, BY LEAD TYPE, 2023–2032 (USD MILLION) 124 TABLE 49 KEY PLAYERS PROVIDING 12-LEAD ECG DEVICES 125 TABLE 50 12-LEAD ECG DEVICES MARKET, BY COUNTRY/REGION, 2023–2032 (USD MILLION) 126 TABLE 51 5-LEAD ECG DEVICES MARKET, BY COUNTRY/REGION, 2023–2032 (USD MILLION) 128 TABLE 52 3-LEAD ECG DEVICES MARKET, BY COUNTRY/REGION, 2023–2032 (USD MILLION) 130 TABLE 53 6-LEAD ECG DEVICES MARKET, BY COUNTRY/REGION, 2023–2032 (USD MILLION) 132 TABLE 54 SINGLE-LEAD ECG DEVICES MARKET, BY COUNTRY/REGION, 2023–2032 (USD MILLION) 134 TABLE 55 OTHER ECG LEAD DEVICES MARKET, BY COUNTRY/REGION, 2023–2032 (USD MILLION) 135 TABLE 56 DIAGNOSTIC ECG MARKET, BY TYPE, 2023–2032 (USD MILLION) 137 TABLE 57 KEY PLAYERS PROVIDING PORTABLE ECG DEVICES 138 TABLE 58 DIAGNOSTIC ECG DEVICES MARKET FOR PORTABLE ECG DEVICES, BY COUNTRY/REGION, 2023–2032 (USD MILLION) 139 TABLE 59 KEY PLAYERS PROVIDING WEARABLE DIAGNOSTIC ECG DEVICES 140 TABLE 60 DIAGNOSTIC ECG DEVICES MARKET FOR WEARABLE ECG DEVICES, BY COUNTRY/REGION, 2023–2032 (USD MILLION) 141 TABLE 61 DIAGNOSTIC ECG DEVICES MARKET FOR IMPLANTABLE ECG DEVICES, BY COUNTRY/REGION, 2023–2032 (USD MILLION) 143 TABLE 62 DIAGNOSTIC ECG MARKET, BY DEPLOYMENT/CONNECTIVITY, 2023–2032 (USD MILLION) 145 TABLE 63 DIAGNOSTIC ECG DEVICES MARKET FOR STANDALONE ECG, BY COUNTRY/REGION, 2023–2032 (USD MILLION) 146 TABLE 64 DIAGNOSTIC ECG DEVICES MARKET FOR PC-BASED ECG DEVICES, BY COUNTRY/REGION, 2023–2032 (USD MILLION) 148 TABLE 65 DIAGNOSTIC ECG DEVICES MARKET FOR CLOUD-BASED ECG DEVICES, BY COUNTRY/REGION, 2023–2032 (USD MILLION) 150 TABLE 66 DIAGNOSTIC ECG MARKET, BY END USER, 2023–2032 (USD MILLION) 152 TABLE 67 DIAGNOSTIC ECG MARKET FOR HOSPITALS, BY COUNTRY/REGION, 2023–2032 (USD MILLION) 153 TABLE 68 DIAGNOSTIC ECG MARKET FOR PRIMARY CARE CENTERS, BY COUNTRY/REGION, 2023–2032 (USD MILLION) 155 TABLE 69 DIAGNOSTIC ECG MARKET FOR CARDIAC CENTERS, BY COUNTRY/REGION, 2023–2032 (USD MILLION) 157 TABLE 70 DIAGNOSTIC ECG MARKET FOR AMBULATORY SURGERY CENTERS, BY COUNTRY/REGION, 2023–2032 (USD MILLION) 159 TABLE 71 DIAGNOSTIC ECG MARKET FOR HOME CARE SETTINGS, BY COUNTRY/REGION, 2023–2032 (USD MILLION) 161 TABLE 72 DIAGNOSTIC ECG MARKET FOR URGENT CARE SETTINGS, BY COUNTRY/REGION, 2023–2032 (USD MILLION) 163 TABLE 73 DIAGNOSTIC ECG MARKET FOR OTHER END USERS, BY COUNTRY/REGION, 2023–2032 (USD MILLION) 165 TABLE 74 DIAGNOSTIC ECG MARKET, BY REGION, 2023–2032 (USD MILLION) 168 TABLE 75 NORTH AMERICA: DIAGNOSTIC ECG MARKET, BY COUNTRY, 2023–2032 (USD MILLION) 169 TABLE 76 NORTH AMERICA: DIAGNOSTIC ECG MARKET, BY PRODUCT, 2023–2032 (USD MILLION) 170 TABLE 77 NORTH AMERICA: DIAGNOSTIC ECG DEVICES MARKET, BY DEVICE TYPE, 2023–2032 (USD MILLION) 170 TABLE 78 NORTH AMERICA: DIAGNOSTIC ECG DEVICES MARKET VOLUME, BY DEVICE TYPE, 2023–2032 (THOUSAND UNITS) 171 TABLE 79 NORTH AMERICA: DIAGNOSTIC ECG MARKET, BY LEAD TYPE, 2023–2032 (USD MILLION) 171 TABLE 80 NORTH AMERICA: DIAGNOSTIC ECG MARKET, BY TYPE, 2023–2032 (USD MILLION) 172 TABLE 81 NORTH AMERICA: DIAGNOSTIC ECG MARKET, BY CONNECTIVITY/DEPLOYMENT, 2023–2032 (USD MILLION) 172 TABLE 82 NORTH AMERICA: DIAGNOSTIC ECG MARKET, BY END USER, 2023–2032 (USD MILLION) 173 TABLE 83 US: KEY MACROINDICATORS 174 TABLE 84 US: DIAGNOSTIC ECG MARKET, BY PRODUCT, 2023–2032 (USD MILLION) 174 TABLE 85 US: DIAGNOSTIC ECG DEVICES MARKET, BY DEVICE TYPE, 2023–2032 (USD MILLION) 174 TABLE 86 US: DIAGNOSTIC ECG MARKET, BY LEAD TYPE, 2023–2032 (USD MILLION) 175 TABLE 87 US: DIAGNOSTIC ECG MARKET, BY TYPE, 2023–2032 (USD MILLION) 175 TABLE 88 US: DIAGNOSTIC ECG MARKET, BY CONNECTIVITY/DEPLOYMENT, 2023–2032 (USD MILLION) 176 TABLE 89 US: DIAGNOSTIC ECG MARKET, BY END USER, 2023–2032 (USD MILLION) 176 TABLE 90 CANADA: KEY MACROINDICATORS 177 TABLE 91 CANADA: DIAGNOSTIC ECG MARKET, BY PRODUCT, 2023–2032 (USD MILLION) 177 TABLE 92 CANADA: DIAGNOSTIC ECG DEVICES MARKET, BY DEVICE TYPE, 2023–2032 (USD MILLION) 178 TABLE 93 CANADA: DIAGNOSTIC ECG MARKET, BY LEAD TYPE, 2023–2032 (USD MILLION) 178 TABLE 94 CANADA: DIAGNOSTIC ECG MARKET, BY TYPE, 2023–2032 (USD MILLION) 179 TABLE 95 CANADA: DIAGNOSTIC ECG MARKET, BY CONNECTIVITY/DEPLOYMENT, 2023–2032 (USD MILLION) 179 TABLE 96 CANADA: DIAGNOSTIC ECG MARKET, BY END USER, 2023–2032 (USD MILLION) 180 TABLE 97 EUROPE: DIAGNOSTIC ECG MARKET, BY COUNTRY, 2023–2032 (USD MILLION) 181 TABLE 98 EUROPE: DIAGNOSTIC ECG MARKET, BY PRODUCT, 2023–2032 (USD MILLION) 181 TABLE 99 EUROPE: DIAGNOSTIC ECG DEVICES MARKET, BY DEVICE TYPE, 2023–2032 (USD MILLION) 182 TABLE 100 EUROPE: DIAGNOSTIC ECG DEVICES MARKET VOLUME, BY DEVICE TYPE, 2023–2032 (THOUSAND UNITS) 182 TABLE 101 EUROPE: DIAGNOSTIC ECG MARKET, BY LEAD TYPE, 2023–2032 (USD MILLION) 183 TABLE 102 EUROPE: DIAGNOSTIC ECG MARKET, BY TYPE, 2023–2032 (USD MILLION) 183 TABLE 103 EUROPE: DIAGNOSTIC ECG MARKET, BY CONNECTIVITY/DEPLOYMENT, 2023–2032 (USD MILLION) 184 TABLE 104 EUROPE: DIAGNOSTIC ECG MARKET, BY END USER, 2023–2032 (USD MILLION) 184 TABLE 105 GERMANY: KEY MACROINDICATORS 185 TABLE 106 GERMANY: DIAGNOSTIC ECG MARKET, BY PRODUCT, 2023–2032 (USD MILLION) 185 TABLE 107 GERMANY: DIAGNOSTIC ECG DEVICES MARKET, BY DEVICE TYPE, 2023–2032 (USD MILLION) 186 TABLE 108 GERMANY: DIAGNOSTIC ECG MARKET, BY LEAD TYPE, 2023–2032 (USD MILLION) 186 TABLE 109 GERMANY: DIAGNOSTIC ECG MARKET, BY TYPE, 2023–2032 (USD MILLION) 187 TABLE 110 GERMANY: DIAGNOSTIC ECG MARKET, BY CONNECTIVITY/DEPLOYMENT, 2023–2032 (USD MILLION) 187 TABLE 111 GERMANY: DIAGNOSTIC ECG MARKET, BY END USER, 2023–2032 (USD MILLION) 188 TABLE 112 FRANCE: KEY MACROINDICATORS 188 TABLE 113 FRANCE: DIAGNOSTIC ECG MARKET, BY PRODUCT, 2023–2032 (USD MILLION) 189 TABLE 114 FRANCE: DIAGNOSTIC ECG DEVICES MARKET, BY DEVICE TYPE, 2023–2032 (USD MILLION) 189 TABLE 115 FRANCE: DIAGNOSTIC ECG MARKET, BY LEAD TYPE, 2023–2032 (USD MILLION) 190 TABLE 116 FRANCE: DIAGNOSTIC ECG MARKET, BY TYPE, 2023–2032 (USD MILLION) 190 TABLE 117 FRANCE: DIAGNOSTIC ECG MARKET, BY CONNECTIVITY/DEPLOYMENT, 2023–2032 (USD MILLION) 190 TABLE 118 FRANCE: DIAGNOSTIC ECG MARKET, BY END USER, 2023–2032 (USD MILLION) 191 TABLE 119 UK: KEY MACROINDICATORS 191 TABLE 120 UK: DIAGNOSTIC ECG MARKET, BY PRODUCT, 2023–2032 (USD MILLION) 192 TABLE 121 UK: DIAGNOSTIC ECG DEVICES MARKET, BY DEVICE TYPE, 2023–2032 (USD MILLION) 192 TABLE 122 UK: DIAGNOSTIC ECG MARKET, BY LEAD TYPE, 2023–2032 (USD MILLION) 193 TABLE 123 UK: DIAGNOSTIC ECG MARKET, BY TYPE, 2023–2032 (USD MILLION) 193 TABLE 124 UK: DIAGNOSTIC ECG MARKET, BY CONNECTIVITY/DEPLOYMENT, 2023–2032 (USD MILLION) 194 TABLE 125 UK: DIAGNOSTIC ECG MARKET, BY END USER, 2023–2032 (USD MILLION) 194 TABLE 126 ITALY: KEY MACROINDICATORS 195 TABLE 127 ITALY: DIAGNOSTIC ECG MARKET, BY PRODUCT, 2023–2032 (USD MILLION) 195 TABLE 128 ITALY: DIAGNOSTIC ECG DEVICES MARKET, BY DEVICE TYPE, 2023–2032 (USD MILLION) 196 TABLE 129 ITALY: DIAGNOSTIC ECG MARKET, BY LEAD TYPE, 2023–2032 (USD MILLION) 196 TABLE 130 ITALY: DIAGNOSTIC ECG MARKET, BY TYPE, 2023–2032 (USD MILLION) 197 TABLE 131 ITALY: DIAGNOSTIC ECG MARKET, BY CONNECTIVITY/DEPLOYMENT, 2023–2032 (USD MILLION) 197 TABLE 132 ITALY: DIAGNOSTIC ECG MARKET, BY END USER, 2023–2032 (USD MILLION) 198 TABLE 133 SPAIN: KEY MACROINDICATORS 199 TABLE 134 SPAIN: DIAGNOSTIC ECG MARKET, BY PRODUCT, 2023–2032 (USD MILLION) 199 TABLE 135 SPAIN: DIAGNOSTIC ECG DEVICES MARKET, BY DEVICE TYPE, 2023–2032 (USD MILLION) 199 TABLE 136 SPAIN: DIAGNOSTIC ECG MARKET, BY LEAD TYPE, 2023–2032 (USD MILLION) 200 TABLE 137 SPAIN: DIAGNOSTIC ECG MARKET, BY TYPE, 2023–2032 (USD MILLION) 200 TABLE 138 SPAIN: DIAGNOSTIC ECG MARKET, BY CONNECTIVITY/DEPLOYMENT, 2023–2032 (USD MILLION) 201 TABLE 139 SPAIN: DIAGNOSTIC ECG MARKET, BY END USER, 2023–2032 (USD MILLION) 201 TABLE 140 REST OF EUROPE: DIAGNOSTIC ECG MARKET, BY PRODUCT, 2023–2032 (USD MILLION) 202 TABLE 141 REST OF EUROPE: DIAGNOSTIC ECG DEVICES MARKET, BY DEVICE TYPE, 2023–2032 (USD MILLION) 202 TABLE 142 REST OF EUROPE: DIAGNOSTIC ECG MARKET, BY LEAD TYPE, 2023–2032 (USD MILLION) 203 TABLE 143 REST OF EUROPE: DIAGNOSTIC ECG MARKET, BY TYPE, 2023–2032 (USD MILLION) 203 TABLE 144 REST OF EUROPE: DIAGNOSTIC ECG MARKET, BY CONNECTIVITY/DEPLOYMENT, 2023–2032 (USD MILLION) 204 TABLE 145 REST OF EUROPE: DIAGNOSTIC ECG MARKET, BY END USER, 2023–2032 (USD MILLION) 204 TABLE 146 ASIA PACIFIC: DIAGNOSTIC ECG MARKET, BY COUNTRY, 2023–2032 (USD MILLION) 207 TABLE 147 ASIA PACIFIC: DIAGNOSTIC ECG MARKET, BY PRODUCT, 2023–2032 (USD MILLION) 207 TABLE 148 ASIA PACIFIC: DIAGNOSTIC ECG DEVICES MARKET, BY DEVICE TYPE, 2023–2032 (USD MILLION) 208 TABLE 149 ASIA PACIFIC: DIAGNOSTIC ECG DEVICES MARKET VOLUME, BY DEVICE TYPE, 2023–2032 (THOUSAND UNITS) 208 TABLE 150 ASIA PACIFIC: DIAGNOSTIC ECG MARKET, BY LEAD TYPE, 2023–2032 (USD MILLION) 209 TABLE 151 ASIA PACIFIC: DIAGNOSTIC ECG MARKET, BY TYPE, 2023–2032 (USD MILLION) 209 TABLE 152 ASIA PACIFIC: DIAGNOSTIC ECG MARKET, BY CONNECTIVITY/DEPLOYMENT, 2023–2032 (USD MILLION) 210 TABLE 153 ASIA PACIFIC: DIAGNOSTIC ECG MARKET, BY END USER, 2023–2032 (USD MILLION) 210 TABLE 154 JAPAN: MACROECONOMIC INDICATORS 211 TABLE 155 JAPAN: DIAGNOSTIC ECG MARKET, BY PRODUCT, 2023–2032 (USD MILLION) 211 TABLE 156 JAPAN: DIAGNOSTIC ECG DEVICES MARKET, BY DEVICE TYPE, 2023–2032 (USD MILLION) 212 TABLE 157 JAPAN: DIAGNOSTIC ECG MARKET, BY LEAD TYPE, 2023–2032 (USD MILLION) 212 TABLE 158 JAPAN: DIAGNOSTIC ECG MARKET, BY TYPE, 2023–2032 (USD MILLION) 213 TABLE 159 JAPAN: DIAGNOSTIC ECG MARKET, BY CONNECTIVITY/DEPLOYMENT, 2023–2032 (USD MILLION) 213 TABLE 160 JAPAN: DIAGNOSTIC ECG MARKET, BY END USER, 2023–2032 (USD MILLION) 214 TABLE 161 CHINA: MACROECONOMIC INDICATORS 215 TABLE 162 CHINA: DIAGNOSTIC ECG MARKET, BY PRODUCT, 2023–2032 (USD MILLION) 215 TABLE 163 CHINA: DIAGNOSTIC ECG DEVICES MARKET, BY DEVICE TYPE, 2023–2032 (USD MILLION) 215 TABLE 164 CHINA: DIAGNOSTIC ECG MARKET, BY LEAD TYPE, 2023–2032 (USD MILLION) 216 TABLE 165 CHINA: DIAGNOSTIC ECG MARKET, BY TYPE, 2023–2032 (USD MILLION) 216 TABLE 166 CHINA: DIAGNOSTIC ECG MARKET, BY CONNECTIVITY/DEPLOYMENT, 2023–2032 (USD MILLION) 217 TABLE 167 CHINA: DIAGNOSTIC ECG MARKET, BY END USER, 2023–2032 (USD MILLION) 217 TABLE 168 INDIA: MACROECONOMIC INDICATORS 218 TABLE 169 INDIA: DIAGNOSTIC ECG MARKET, BY PRODUCT, 2023–2032 (USD MILLION) 218 TABLE 170 INDIA: DIAGNOSTIC ECG DEVICES MARKET, BY DEVICE TYPE, 2023–2032 (USD MILLION) 219 TABLE 171 INDIA: DIAGNOSTIC ECG MARKET, BY LEAD TYPE, 2023–2032 (USD MILLION) 219 TABLE 172 INDIA: DIAGNOSTIC ECG MARKET, BY TYPE, 2023–2032 (USD MILLION) 220 TABLE 173 INDIA: DIAGNOSTIC ECG MARKET, BY CONNECTIVITY/DEPLOYMENT, 2023–2032 (USD MILLION) 220 TABLE 174 INDIA: DIAGNOSTIC ECG MARKET, BY END USER, 2023–2032 (USD MILLION) 221 TABLE 175 AUSTRALIA: KEY MACROINDICATORS 221 TABLE 176 AUSTRALIA: DIAGNOSTIC ECG MARKET, BY PRODUCT, 2023–2032 (USD MILLION) 222 TABLE 177 AUSTRALIA: DIAGNOSTIC ECG DEVICES MARKET, BY DEVICE TYPE, 2023–2032 (USD MILLION) 222 TABLE 178 AUSTRALIA: DIAGNOSTIC ECG MARKET, BY LEAD TYPE, 2023–2032 (USD MILLION) 223 TABLE 179 AUSTRALIA: DIAGNOSTIC ECG MARKET, BY TYPE, 2023–2032 (USD MILLION) 223 TABLE 180 AUSTRALIA: DIAGNOSTIC ECG MARKET, BY CONNECTIVITY/DEPLOYMENT, 2023–2032 (USD MILLION) 223 TABLE 181 AUSTRALIA: DIAGNOSTIC ECG MARKET, BY END USER, 2023–2032 (USD MILLION) 224 TABLE 182 SOUTH KOREA: MACROECONOMIC INDICATORS 225 TABLE 183 SOUTH KOREA: DIAGNOSTIC ECG MARKET, BY PRODUCT, 2023–2032 (USD MILLION) 225 TABLE 184 SOUTH KOREA: DIAGNOSTIC ECG DEVICES MARKET, BY DEVICE TYPE, 2023–2032 (USD MILLION) 225 TABLE 185 SOUTH KOREA: DIAGNOSTIC ECG MARKET, BY LEAD TYPE, 2023–2032 (USD MILLION) 226 TABLE 186 SOUTH KOREA: DIAGNOSTIC ECG MARKET, BY TYPE, 2023–2032 (USD MILLION) 226 TABLE 187 SOUTH KOREA: DIAGNOSTIC ECG MARKET, BY CONNECTIVITY/DEPLOYMENT, 2023–2032 (USD MILLION) 226 TABLE 188 SOUTH KOREA: DIAGNOSTIC ECG MARKET, BY END USER, 2023–2032 (USD MILLION) 227 TABLE 189 MALAYSIA: DIAGNOSTIC ECG MARKET, BY PRODUCT, 2023–2032 (USD MILLION) 228 TABLE 190 MALAYSIA: DIAGNOSTIC ECG DEVICES MARKET, BY DEVICE TYPE, 2023–2032 (USD MILLION) 228 TABLE 191 MALAYSIA: DIAGNOSTIC ECG MARKET, BY LEAD TYPE, 2023–2032 (USD MILLION) 229 TABLE 192 MALAYSIA: DIAGNOSTIC ECG MARKET, BY TYPE, 2023–2032 (USD MILLION) 229 TABLE 193 MALAYSIA: DIAGNOSTIC ECG MARKET, BY CONNECTIVITY/DEPLOYMENT, 2023–2032 (USD MILLION) 229 TABLE 194 MALAYSIA: DIAGNOSTIC ECG MARKET, BY END USER, 2023–2032 (USD MILLION) 230 TABLE 195 THAILAND: MACROECONOMIC INDICATORS 231 TABLE 196 THAILAND: DIAGNOSTIC ECG MARKET, BY PRODUCT, 2023–2032 (USD MILLION) 231 TABLE 197 THAILAND: DIAGNOSTIC ECG DEVICES MARKET, BY DEVICE TYPE, 2023–2032 (USD MILLION) 231 TABLE 198 THAILAND: DIAGNOSTIC ECG MARKET, BY LEAD TYPE, 2023–2032 (USD MILLION) 232 TABLE 199 THAILAND: DIAGNOSTIC ECG MARKET, BY TYPE, 2023–2032 (USD MILLION) 232 TABLE 200 THAILAND: DIAGNOSTIC ECG MARKET, BY CONNECTIVITY/DEPLOYMENT, 2023–2032 (USD MILLION) 232 TABLE 201 THAILAND: DIAGNOSTIC ECG MARKET, BY END USER, 2023–2032 (USD MILLION) 233 TABLE 202 INDONESIA: MACROECONOMIC INDICATORS 234 TABLE 203 INDONESIA: DIAGNOSTIC ECG MARKET, BY PRODUCT, 2023–2032 (USD MILLION) 234 TABLE 204 INDONESIA: DIAGNOSTIC ECG DEVICES MARKET, BY DEVICE TYPE, 2023–2032 (USD MILLION) 234 TABLE 205 INDONESIA: DIAGNOSTIC ECG MARKET, BY LEAD TYPE, 2023–2032 (USD MILLION) 235 TABLE 206 INDONESIA: DIAGNOSTIC ECG MARKET, BY TYPE, 2023–2032 (USD MILLION) 235 TABLE 207 INDONESIA: DIAGNOSTIC ECG MARKET, BY CONNECTIVITY/DEPLOYMENT, 2023–2032 (USD MILLION) 235 TABLE 208 INDONESIA: DIAGNOSTIC ECG MARKET, BY END USER, 2023–2032 (USD MILLION) 236 TABLE 209 REST OF ASIA PACIFIC: DIAGNOSTIC ECG MARKET, BY PRODUCT, 2023–2032 (USD MILLION) 237 TABLE 210 REST OF ASIA PACIFIC: DIAGNOSTIC ECG DEVICES MARKET, BY DEVICE TYPE, 2023–2032 (USD MILLION) 237 TABLE 211 REST OF ASIA PACIFIC: DIAGNOSTIC ECG MARKET, BY LEAD TYPE, 2023–2032 (USD MILLION) 238 TABLE 212 REST OF ASIA PACIFIC: DIAGNOSTIC ECG MARKET, BY TYPE, 2023–2032 (USD MILLION) 238 TABLE 213 REST OF ASIA PACIFIC: DIAGNOSTIC ECG MARKET, BY CONNECTIVITY/DEPLOYMENT, 2023–2032 (USD MILLION) 239 TABLE 214 REST OF ASIA PACIFIC: DIAGNOSTIC ECG MARKET, BY END USER, 2023–2032 (USD MILLION) 239 TABLE 215 LATIN AMERICA: DIAGNOSTIC ECG MARKET, BY COUNTRY, 2023–2032 (USD MILLION) 240 TABLE 216 LATIN AMERICA: DIAGNOSTIC ECG MARKET, BY PRODUCT, 2023–2032 (USD MILLION) 240 TABLE 217 LATIN AMERICA: DIAGNOSTIC ECG DEVICES MARKET, BY DEVICE TYPE, 2023–2032 (USD MILLION) 241 TABLE 218 LATIN AMERICA: DIAGNOSTIC ECG DEVICES MARKET VOLUME, BY DEVICE TYPE, 2023–2032 (THOUSAND UNITS) 241 TABLE 219 LATIN AMERICA: DIAGNOSTIC ECG MARKET, BY LEAD TYPE, 2023–2032 (USD MILLION) 242 TABLE 220 LATIN AMERICA: DIAGNOSTIC ECG MARKET, BY TYPE, 2023–2032 (USD MILLION) 242 TABLE 221 LATIN AMERICA: DIAGNOSTIC ECG MARKET, BY CONNECTIVITY/DEPLOYMENT, 2023–2032 (USD MILLION) 242 TABLE 222 LATIN AMERICA: DIAGNOSTIC ECG MARKET, BY END USER, 2023–2032 (USD MILLION) 243 TABLE 223 BRAZIL: MACROECONOMIC INDICATORS 244 TABLE 224 BRAZIL: DIAGNOSTIC ECG MARKET, BY PRODUCT, 2023–2032 (USD MILLION) 244 TABLE 225 BRAZIL: DIAGNOSTIC ECG DEVICES MARKET, BY DEVICE TYPE, 2023–2032 (USD MILLION) 244 TABLE 226 BRAZIL: DIAGNOSTIC ECG MARKET, BY LEAD TYPE, 2023–2032 (USD MILLION) 245 TABLE 227 BRAZIL: DIAGNOSTIC ECG MARKET, BY TYPE, 2023–2032 (USD MILLION) 245 TABLE 228 BRAZIL: DIAGNOSTIC ECG MARKET, BY CONNECTIVITY/DEPLOYMENT, 2023–2032 (USD MILLION) 245 TABLE 229 BRAZIL: DIAGNOSTIC ECG MARKET, BY END USER, 2023–2032 (USD MILLION) 246 TABLE 230 MEXICO: MACROECONOMIC INDICATORS 247 TABLE 231 MEXICO: DIAGNOSTIC ECG MARKET, BY PRODUCT, 2023–2032 (USD MILLION) 247 TABLE 232 MEXICO: DIAGNOSTIC ECG DEVICES MARKET, BY DEVICE TYPE, 2023–2032 (USD MILLION) 247 TABLE 233 MEXICO: DIAGNOSTIC ECG MARKET, BY LEAD TYPE, 2023–2032 (USD MILLION) 248 TABLE 234 MEXICO: DIAGNOSTIC ECG MARKET, BY TYPE, 2023–2032 (USD MILLION) 248 TABLE 235 MEXICO: DIAGNOSTIC ECG MARKET, BY CONNECTIVITY/DEPLOYMENT, 2023–2032 (USD MILLION) 248 TABLE 236 MEXICO: DIAGNOSTIC ECG MARKET, BY END USER, 2023–2032 (USD MILLION) 249 TABLE 237 REST OF LATIN AMERICA: DIAGNOSTIC ECG MARKET, BY PRODUCT, 2023–2032 (USD MILLION) 249 TABLE 238 REST OF LATIN AMERICA: DIAGNOSTIC ECG DEVICES MARKET, BY DEVICE TYPE, 2023–2032 (USD MILLION) 250 TABLE 239 REST OF LATIN AMERICA: DIAGNOSTIC ECG MARKET, BY LEAD TYPE, 2023–2032 (USD MILLION) 250 TABLE 240 REST OF LATIN AMERICA: DIAGNOSTIC ECG MARKET, BY TYPE, 2023–2032 (USD MILLION) 251 TABLE 241 REST OF LATIN AMERICA: DIAGNOSTIC ECG MARKET, BY CONNECTIVITY/DEPLOYMENT, 2023–2032 (USD MILLION) 251 TABLE 242 REST OF LATIN AMERICA: DIAGNOSTIC ECG MARKET, BY END USER, 2023–2032 (USD MILLION) 252 TABLE 243 MIDDLE EAST & AFRICA: DIAGNOSTIC ECG MARKET, BY COUNTRY, 2023–2032 (USD MILLION) 253 TABLE 244 MIDDLE EAST & AFRICA: DIAGNOSTIC ECG MARKET, BY PRODUCT, 2023–2032 (USD MILLION) 253 TABLE 245 MIDDLE EAST & AFRICA: DIAGNOSTIC ECG DEVICES MARKET, BY DEVICE TYPE, 2023–2032 (USD MILLION) 254 TABLE 246 MIDDLE EAST AND AFRICA : DIAGNOSTIC ECG DEVICES MARKET VOLUME, BY DEVICE TYPE, 2023–2032 (THOUSAND UNITS) 254 TABLE 247 MIDDLE EAST & AFRICA: DIAGNOSTIC ECG MARKET, BY LEAD TYPE, 2023–2032 (USD MILLION) 255 TABLE 248 MIDDLE EAST & AFRICA: DIAGNOSTIC ECG MARKET, BY TYPE, 2023–2032 (USD MILLION) 255 TABLE 249 MIDDLE EAST & AFRICA: DIAGNOSTIC ECG MARKET, BY CONNECTIVITY/DEPLOYMENT, 2023–2032 (USD MILLION) 256 TABLE 250 MIDDLE EAST & AFRICA: DIAGNOSTIC ECG MARKET, BY END USER, 2023–2032 (USD MILLION) 256 TABLE 251 GCC COUNTRIES: DIAGNOSTIC ECG MARKET, BY COUNTRY, 2023–2032 (USD MILLION) 257 TABLE 252 GCC COUNTRIES: DIAGNOSTIC ECG MARKET, BY PRODUCT, 2023–2032 (USD MILLION) 257 TABLE 253 GCC COUNTRIES: DIAGNOSTIC ECG DEVICES MARKET, BY DEVICE TYPE, 2023–2032 (USD MILLION) 258 TABLE 254 GCC COUNTRIES: DIAGNOSTIC ECG MARKET, BY LEAD TYPE, 2023–2032 (USD MILLION) 258 TABLE 255 GCC COUNTRIES: DIAGNOSTIC ECG MARKET, BY TYPE, 2023–2032 (USD MILLION) 259 TABLE 256 GCC COUNTRIES: DIAGNOSTIC ECG MARKET, BY CONNECTIVITY/DEPLOYMENT, 2023–2032 (USD MILLION) 259 TABLE 257 GCC COUNTRIES: DIAGNOSTIC ECG MARKET, BY END USER, 2023–2032 (USD MILLION) 260 TABLE 258 KSA: KEY MACROINDICATORS 260 TABLE 259 KINGDOM OF SAUDI ARABIA (KSA): DIAGNOSTIC ECG MARKET, BY PRODUCT, 2023–2032 (USD MILLION) 261 TABLE 260 KINGDOM OF SAUDI ARABIA (KSA): DIAGNOSTIC ECG DEVICES MARKET, BY DEVICE TYPE, 2023–2032 (USD MILLION) 261 TABLE 261 KINGDOM OF SAUDI ARABIA (KSA): DIAGNOSTIC ECG MARKET, BY LEAD TYPE, 2023–2032 (USD MILLION) 262 TABLE 262 KINGDOM OF SAUDI ARABIA (KSA): DIAGNOSTIC ECG MARKET, BY TYPE, 2023–2032 (USD MILLION) 262 TABLE 263 KINGDOM OF SAUDI ARABIA (KSA): DIAGNOSTIC ECG MARKET, BY CONNECTIVITY/DEPLOYMENT, 2023–2032 (USD MILLION) 263 TABLE 264 KINGDOM OF SAUDI ARABIA (KSA): DIAGNOSTIC ECG MARKET, BY END USER, 2023–2032 (USD MILLION) 263 TABLE 265 UAE: KEY MACROINDICATORS 264 TABLE 266 UNITED ARAB EMIRATES (UAE): DIAGNOSTIC ECG MARKET, BY PRODUCT, 2023–2032 (USD MILLION) 264 TABLE 267 UNITED ARAB EMIRATES (UAE): DIAGNOSTIC ECG DEVICES MARKET, BY DEVICE TYPE, 2023–2032 (USD MILLION) 265 TABLE 268 UNITED ARAB EMIRATES (UAE): DIAGNOSTIC ECG MARKET, BY LEAD TYPE, 2023–2032 (USD MILLION) 265 TABLE 269 UNITED ARAB EMIRATES (UAE): DIAGNOSTIC ECG MARKET, BY TYPE, 2023–2032 (USD MILLION) 266 TABLE 270 UNITED ARAB EMIRATES (UAE): DIAGNOSTIC ECG MARKET, BY CONNECTIVITY/DEPLOYMENT, 2023–2032 (USD MILLION) 266 TABLE 271 UNITED ARAB EMIRATES (UAE): DIAGNOSTIC ECG MARKET, BY END USER, 2023–2032 (USD MILLION) 267 TABLE 272 REST OF GCC COUNTRIES: DIAGNOSTIC ECG MARKET, BY PRODUCT, 2023–2032 (USD MILLION) 268 TABLE 273 REST OF GCC COUNTRIES: DIAGNOSTIC ECG DEVICES MARKET, BY DEVICE TYPE, 2023–2032 (USD MILLION) 268 TABLE 274 REST OF GCC COUNTRIES: DIAGNOSTIC ECG MARKET, BY LEAD TYPE, 2023–2032 (USD MILLION) 269 TABLE 275 REST OF GCC COUNTRIES: DIAGNOSTIC ECG MARKET, BY TYPE, 2023–2032 (USD MILLION) 269 TABLE 276 REST OF GCC COUNTRIES: DIAGNOSTIC ECG MARKET, BY CONNECTIVITY/DEPLOYMENT, 2023–2032 (USD MILLION) 270 TABLE 277 REST OF GCC COUNTRIES: DIAGNOSTIC ECG MARKET, BY END USER, 2023–2032 (USD MILLION) 270 TABLE 278 REST OF MIDDLE EAST & AFRICA: DIAGNOSTIC ECG MARKET, BY PRODUCT, 2023–2032 (USD MILLION) 271 TABLE 279 REST OF MIDDLE EAST & AFRICA: DIAGNOSTIC ECG DEVICES MARKET, BY DEVICE TYPE, 2023–2032 (USD MILLION) 271 TABLE 280 REST OF MIDDLE EAST & AFRICA: DIAGNOSTIC ECG MARKET, BY LEAD TYPE, 2023–2032 (USD MILLION) 272 TABLE 281 REST OF MIDDLE EAST & AFRICA: DIAGNOSTIC ECG MARKET, BY TYPE, 2023–2032 (USD MILLION) 272 TABLE 282 REST OF MIDDLE EAST & AFRICA: DIAGNOSTIC ECG MARKET, BY CONNECTIVITY/DEPLOYMENT, 2023–2032 (USD MILLION) 273 TABLE 283 REST OF MIDDLE EAST & AFRICA: DIAGNOSTIC ECG MARKET, BY END USER, 2023–2032 (USD MILLION) 273 TABLE 284 OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS IN DIAGNOSTIC ECG MARKET 274 TABLE 285 DIAGNOSTIC ECG MARKET: DEGREE OF COMPETITION, 2024 278 TABLE 286 DIAGNOSTIC ECG MARKET: REGION FOOTPRINT 283 TABLE 287 DIAGNOSTIC ECG MARKET: PRODUCT FOOTPRINT 284 TABLE 288 DIAGNOSTIC ECG MARKET: LEAD TYPE FOOTPRINT 285 TABLE 289 DIAGNOSTIC ECG MARKET: TYPE FOOTPRINT 286 TABLE 290 DIAGNOSTIC ECG MARKET: DEPLOYMENT/CONNECTIVITY FOOTPRINT 287 TABLE 291 DIAGNOSTIC ECG MARKET: DETAILED LIST OF KEY STARTUP/SME PLAYERS 289 TABLE 292 DIAGNOSTIC ECG MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SME PLAYERS 290 TABLE 293 DIAGNOSTIC ECG MARKET: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022–MARCH 2025 293 TABLE 294 DIAGNOSTIC ECG MARKET: DEALS, JANUARY 2022–MARCH 2025 295 TABLE 295 DIAGNOSTIC ECG MARKET: EXPANSIONS, JANUARY 2022–MARCH 2025 297 TABLE 296 DIAGNOSTIC ECG MARKET: OTHER DEVELOPMENTS, JANUARY 2022–MARCH 2025 298 TABLE 297 KONINKLIJKE PHILIPS N.V.: COMPANY OVERVIEW 300 TABLE 298 KONINKLIJKE PHILIPS N. V.: PRODUCTS/SERVICES/SOLUTIONS OFFERED 301 TABLE 299 KONINKLIJKE PHILIPS N. V.: PRODUCT/SERVICE LAUNCHES, JANUARY 2022–APRIL 2025 303 TABLE 300 KONINKLIJKE PHILIPS N. V.: DEALS, JANUARY 2022–APRIL 2025 304 TABLE 301 KONINKLIJKE PHILIPS N. V.: OTHER DEVELOPMENTS, JANUARY 2022–APRIL 2025 304 TABLE 302 GE HEALTHCARE: COMPANY OVERVIEW 306 TABLE 303 GE HEALTHCARE: PRODUCTS OFFERED 307 TABLE 304 GE HEALTHCARE: DEALS, JANUARY 2022–APRIL 2025 308 TABLE 305 GE HEALTHCARE: OTHER DEVELOPMENTS, JANUARY 2022–APRIL 2025 309 TABLE 306 MEDTRONIC: COMPANY OVERVIEW 311 TABLE 307 MEDTRONIC: PRODUCTS OFFERED 312 TABLE 308 BOSTON SCIENTIFIC CORPORATION: BUSINESS OVERVIEW 314 TABLE 309 BOSTON SCIENTIFIC CORPORATION: PRODUCTS OFFERED 316 TABLE 310 ABBOTT LABORATORIES: COMPANY OVERVIEW 317 TABLE 311 ABBOTT: PRODUCTS OFFERED 318 TABLE 312 ABBOTT: PRODUCT LAUNCHES, JANUARY 2022–APRIL 2025 319 TABLE 313 BAXTER: COMPANY OVERVIEW 320 TABLE 314 BAXTER: PRODUCTS OFFERED 321 TABLE 315 FUKUDA DENSHI: COMPANY OVERVIEW 325 TABLE 316 FUKUDA DENSHI: PRODUCTS OFFERED 326 TABLE 317 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.: COMPANY OVERVIEW 328 TABLE 318 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.: PRODUCTS OFFERED 329 TABLE 319 NIHON KOHDEN CORPORATION: COMPANY OVERVIEW 331 TABLE 320 NIHON KOHDEN CORPORATION: PRODUCTS OFFERED 332 TABLE 321 OSI SYSTEMS, INC: COMPANY OVERVIEW 334 TABLE 322 OSI SYSTEMS, INC.: PRODUCTS OFFERED 335 TABLE 323 OSI SYSTEMS, INC.: EXPANSIONS, JANUARY 2022–APRIL 2025 336 TABLE 324 BITTIUM: COMPANY OVERVIEW 337 TABLE 325 BITTIUM: PRODUCTS OFFERED 338 TABLE 326 BITTIUM: DEALS, JANUARY 2022–APRIL 2025 339 TABLE 327 IRHYTHM TECHNOLOGIES, INC.: COMPANY OVERVIEW 340 TABLE 328 IRHYTHM TECHNOLOGIES, INC.: PRODUCTS OFFERED 341 TABLE 329 IRHYTHM TECHNOLOGIES, INC.: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2022–APRIL 2025 341 TABLE 330 IRHYTHM TECHNOLOGIES, INC.: DEALS, JANUARY 2022–APRIL 2025 342 TABLE 331 LEPU MEDICAL TECHNOLOGY (BEIJING) CO., LTD.: COMPANY OVERVIEW 343 TABLE 332 LEPU MEDICAL TECHNOLOGY (BEIJING) CO., LTD.: PRODUCTS OFFERED 344 TABLE 333 LEPU MEDICAL TECHNOLOGY (BEIJING) CO., LTD.: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2022–APRIL 2025 345 TABLE 334 LEPU MEDICAL TECHNOLOGY (BEIJING) CO., LTD.: OTHER DEVELOPMENTS, JANUARY 2022–APRIL 2025 346 TABLE 335 MIDMARK CORPORATION: COMPANY OVERVIEW 347 TABLE 336 MIDMARK CORPORATION: PRODUCTS OFFERED 347 TABLE 337 MIDMARK CORPORATION: PRODUCT LAUNCH, JANUARY 2022–APRIL 2025 348 TABLE 338 BPL MEDICAL TECHNOLOGIES: COMPANY OVERVIEW 349 TABLE 339 BPL MEDICAL TECHNOLOGIES: PRODUCTS OFFERED 349 TABLE 340 BPL MEDICAL TECHNOLOGIES: EXPANSIONS, JANUARY 2022–APRIL 2025 350 TABLE 341 BPL MEDICAL TECHNOLOGIES: OTHER DEVELOPMENTS, JANUARY 2022–APRIL 2025 351 TABLE 342 SCHILLER: COMPANY OVERVIEW 352 TABLE 343 SCHILLER: PRODUCTS OFFERED 352 TABLE 344 SCHILLER: PRODUCT LAUNCH, JANUARY 2022–APRIL 2025 353 TABLE 345 SCHILLER: OTHER DEVELOPMENTS, JANUARY 2022–APRIL 2025 353 TABLE 346 ACS DIAGNOSTICS: COMPANY OVERVIEW 354 TABLE 347 ACS DIAGNOSTICS: PRODUCTS OFFERED 354 TABLE 348 ALLENGERS: COMPANY OVERVIEW 355 TABLE 349 ALLENGERS: PRODUCTS OFFERED 355 TABLE 350 BIONET CO., LTD.: COMPANY OVERVIEW 356 TABLE 351 BIONET CO., LTD.: PRODUCTS OFFERED 356 TABLE 352 BIONET CO., LTD.: OTHER DEVELOPMENTS, JANUARY 2022–APRIL 2025 357 FIGURE 1 DIAGNOSTIC ECG MARKET: SEGMENTS CONSIDERED & GEOGRAPHICAL SCOPE 31 FIGURE 2 DIAGNOSTIC ECG MARKET: YEARS CONSIDERED 33 FIGURE 3 DIAGNOSTIC ECG MARKET: RESEARCH DESIGN 35 FIGURE 4 DIAGNOSTIC ECG MARKET: KEY PRIMARY SOURCES 38 FIGURE 5 DIAGNOSTIC ECG MARKET: INSIGHTS FROM PRIMARIES 39 FIGURE 6 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS 39 FIGURE 7 BREAKDOWN OF PRIMARIES, BY COMPANY TYPE, DESIGNATION, AND REGION 40 FIGURE 8 DIAGNOSTIC ECG MARKET SIZE ESTIMATION: SUPPLY-SIDE ANALYSIS (2024) 40 FIGURE 9 DIAGNOSTIC ECG: MARKET SIZE ESTIMATION 41 FIGURE 10 TOP-DOWN APPROACH 42 FIGURE 11 BOTTOM-UP APPROACH 43 FIGURE 12 DATA TRIANGULATION METHODOLOGY 45 FIGURE 13 DIAGNOSTIC ECG MARKET, BY PRODUCT, 2025 VS. 2032 (USD MILLION) 48 FIGURE 14 DIAGNOSTIC ECG MARKET, BY LEAD TYPE, 2025 VS. 2032 (USD MILLION) 49 FIGURE 15 DIAGNOSTIC ECG MARKET, BY TYPE, 2025 VS. 2032 (USD MILLION) 49 FIGURE 16 DIAGNOSTIC ECG MARKET, BY DEPLOYMENT/CONNECTIVITY, 2025 VS. 2032 (USD MILLION) 50 FIGURE 17 DIAGNOSTIC ECG MARKET, BY END USER, 2025 VS. 2032 (USD MILLION) 50 FIGURE 18 GEOGRAPHICAL SNAPSHOT OF DIAGNOSTIC ECG MARKET 51 FIGURE 19 INCREASING PREVALENCE OF CARDIOVASCULAR DISEASES GLOBALLY TO DRIVE MARKET GROWTH 52 FIGURE 20 DEVICES SEGMENT ACCOUNTED FOR LARGEST SHARE OF NORTH AMERICAN DIAGNOSTIC ECG MARKET IN 2024 53 FIGURE 21 RESTING ECG DEVICES TO CAPTURE LARGEST SHARE OF DIAGNOSTIC ECG DEVICES MARKET IN 2025 53 FIGURE 22 12-LEAD ECG DEVICES SEGMENT TO CONTINUE TO DOMINATE MARKET IN 2032 54 FIGURE 23 HOSPITALS, CLINICS, AND CARDIAC CENTERS SEGMENT TO DOMINATE MARKET IN 2032 55 FIGURE 24 CHINA TO REGISTER HIGHEST GROWTH IN DIAGNOSTIC ECG MARKET FROM 2025 TO 2032 56 FIGURE 25 DIAGNOSTIC ECG MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 57 FIGURE 26 DIAGNOSTIC ECG MARKET: PORTER’S FIVE FORCES ANALYSIS 67 FIGURE 27 DIAGNOSTIC ECG MARKET: NUMBER OF GRANTED PATENT APPLICATIONS (JANUARY 2014–MAY 2025) 74 FIGURE 28 TOP APPLICANT COUNTRIES/REGIONS FOR DIAGNOSTIC ECG PATENTS (JANUARY 2014–MAY 2025) 75 FIGURE 29 AVERAGE SELLING PRICE FOR RESTING ECG, BY KEY PLAYER, 2024 78 FIGURE 30 AVERAGE SELLING PRICE FOR STRESS ECG, BY KEY PLAYER, 2024 78 FIGURE 31 AVERAGE SELLING PRICE OF HOLTER MONITORS, BY KEY PLAYER, 2024 79 FIGURE 32 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR DIAGNOSTIC ECG PRODUCTS 82 FIGURE 33 KEY BUYING CRITERIA FOR DIAGNOSTIC ECG PRODUCTS 83 FIGURE 34 DIAGNOSTIC ECG MARKET: VALUE CHAIN ANALYSIS 85 FIGURE 35 DIAGNOSTIC ECG MARKET: SUPPLY CHAIN ANALYSIS 87 FIGURE 36 DIAGNOSTIC ECG MARKET: ECOSYSTEM ANALYSIS 89 FIGURE 37 AI USE CASES 91 FIGURE 38 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 95 FIGURE 39 DIAGNOSTIC ECG MARKET: INVESTMENT AND FUNDING SCENARIO, 2020–2024 102 FIGURE 40 DIAGNOSTIC ECG MARKET: GEOGRAPHIC SNAPSHOT 167 FIGURE 41 NORTH AMERICA: DIAGNOSTIC ECG MARKET SNAPSHOT 169 FIGURE 42 ASIA PACIFIC: DIAGNOSTIC ECG MARKET SNAPSHOT 206 FIGURE 43 REVENUE SHARE ANALYSIS OF TOP FIVE PLAYERS IN DIAGNOSTIC ECG MARKET (2022–2024) 277 FIGURE 44 DIAGNOSTIC ECG MARKET SHARE ANALYSIS, 2024 278 FIGURE 45 RANKING OF KEY PLAYERS IN DIAGNOSTIC ECG MARKET, 2024 280 FIGURE 46 DIAGNOSTIC ECG MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024 281 FIGURE 47 DIAGNOSTIC ECG MARKET: COMPANY FOOTPRINT 282 FIGURE 48 DIAGNOSTIC ECG MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024 288 FIGURE 49 DIAGNOSTIC ECG MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS 291 FIGURE 50 EV/EBITDA OF KEY VENDORS 292 FIGURE 51 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS 292 FIGURE 52 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT, 2024 301 FIGURE 53 GE HEALTHCARE: COMPANY SNAPSHOT, 2024 307 FIGURE 54 MEDTRONIC: COMPANY SNAPSHOT (2024) 312 FIGURE 55 BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT (2024) 315 FIGURE 56 ABBOTT LABORATORIES: COMPANY SNAPSHOT (2024) 318 FIGURE 57 BAXTER: COMPANY SNAPSHOT, 2024 321 FIGURE 58 FUKUDA DENSHI: COMPANY SNAPSHOT, 2024 326 FIGURE 59 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.: COMPANY SNAPSHOT, 2024 329 FIGURE 60 NIHON KOHDEN CORPORATION: COMPANY SNAPSHOT, 2024 332 FIGURE 61 OSI SYSTEMS, INC.: COMPANY SNAPSHOT, 2024 335 FIGURE 62 BITTIUM: COMPANY SNAPSHOT, 2024 338 FIGURE 63 IRHYTHM TECHNOLOGIES, INC.: COMPANY SNAPSHOT, 2024 340 FIGURE 64 LEPU MEDICAL TECHNOLOGY (BEIJING) CO., LTD.: COMPANY SNAPSHOT, 2024 344

Single User Licence	$4,950 USD
Multi User Licence	$6,650 USD
Corporate User Licence	$8,150 USD
Global User Licence	$10,000 USD

Diagnostic Electrocardiograph/ECG Market by Product (Resting ECG, Stress ECG, Mobile Cardiac Telemetry), Lead Type (Single-lead, 3, 5, 6 & 12-lead ECG Device), Type (Portable ECG Device, Wearable ECG Device), Connectivity - Global Forecast to 2032

授權報價

報告摘要

同分類最新報告（醫療器材）